Skip to main content
  • Original article
  • Open access
  • Published:

Relationship between omentin-1 and carotid intima thickness in type 2 diabetes mellitus



Omentin-1 is a novel adipokine that has a pivotal role in modulating insulin sensitivity, immunity. and inflammation. Adipokines contribute directly to the atherosclerotic process. The current study was conducted to evaluate the serum omentin-1 level in type 2 diabetes mellitus (DM) patients and to evaluate its relationship with carotid intima media thickness (CIMT).

Patients and methods

Sixty participants were enrolled in the study: 30 patients with type 2 DM and 30 controls with normal glucose levels. Patients were classified into group I, which included 15 patients with CIMT greater than 0.9 mm, and group II, including 15 patients with CIMT less than 0.9 mm. All groups were subjected to full medical history taking, clinical examination, and assessment of fasting blood glucose levels, lipid profile, and serum omentin-1 levels using enzyme-linked immunosorbent assay. BMI and CIMT were also assessed using color Doppler ultrasound.


Serum omentin-1 levels were significantly decreased in patients with type 2 DM compared with controls and were further decreased in patients with increased CIMT.

Omentin-1 levels were negatively correlated with fasting blood sugar, BMI, waist circumference. lipid profile, and CIMT, and were positively correlated with high-density lipoprotein, with r-values of −0.72, −0.9, and −0.81 for fetal bovine serum, BMI, and CIMT, respectively; −0.58, −0.70, and −0.49 for triglyceride, low-density lipoprotein, and cholesterol, respectively; and +0.66 for high-density lipoprotein.


Serum omentin-1 level is decreased in type 2 DM patients and is negatively correlated with CIMT and BMI. Hence, omentin-1 could serve as a protective marker and predictor for cardiovascular disease. Further study needed to show whether omentin-1 is considered as a risk factor for DM.


  1. Wild S, Roglic G, Green A, Sicree R, Kg H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.

    Article  Google Scholar 

  2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13 000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422–1426.

    Article  Google Scholar 

  3. Fantuzzi G, Mazzone T. Adispose tissue and atherosclerosis exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996–1003.

    Article  CAS  Google Scholar 

  4. Yang RZ, Lee Mj, Hu H, Pray j, WuHB, Hansen Bc, et al. Identification of omentin as novel depot specific adipokine in human adipose tissue possible role in modulating insulin action. Am J Physiology Endocrinol Metal 2006; 290: E12353–E12361.

    Google Scholar 

  5. Schattier A, Neumeier M, Herfarth H, Furst A, Scholmerich J, Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96–102.

    Article  Google Scholar 

  6. Gerwick L, Gen E. Transcript changes in individual rainbow trout livers following an inflammatory stimulation. Fish Shellfish Immunol 2007; 22: 157–171.

    Article  CAS  Google Scholar 

  7. De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56: 1655–1661.

    Article  Google Scholar 

  8. Elbein Sc, Hoffman MD, Teng K, Lepper TMF. A genome-wide search for type 2 diabetes susceptibility genes in Caucasians. Diabetes 1999; 48: 1175–1182.

    Article  CAS  Google Scholar 

  9. Fu M, Gong DW, Damcott C, Sabra M, Yang RZ, Pollin TI, et al. Systematic analysis of omentin 1 and ometin 2 on 1q23 as candidate genes for type 2 diabetes in the old order Amish. Diabetes 2004; 53: 59.

    Article  Google Scholar 

  10. Kershaw EE, Flier Js. Adipose tissue as an endocrine organ. J Clin Endocrinal Metab 2004; 89: 2548–2556.

    Article  CAS  Google Scholar 

  11. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O’Hare P, Lehnert H, Randeva HS. Omentin-1, a novel adipokine, is decreased in overweight insulin resistant women with polycystic ovary syndrome ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008; 57: 801–808.

    Article  CAS  Google Scholar 

  12. Pan HY, Guo L, Li Q. Change of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010; 88: 29–33.

    Article  CAS  Google Scholar 

  13. Yamawaki H, Tsubaki N, Moukohda M, Okada M, Hara Y. Omentin is a novel adipokine induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010; 393: 668–672.

    Article  CAS  Google Scholar 

  14. Shibata R, Takahashi R, Kataoka Y, Ohashi k, Ikeda N, kihara s, et al. Association of fat-dervived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res 2011; 34: 1309–1312.

    Article  CAS  Google Scholar 

  15. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sinica 2011 ; 32: 873–878.

    Article  CAS  Google Scholar 

  16. Greulich S, chen WJ, Maxhera B, RijzeijL J, Van der Meer RW, Jonker JT, et al. Cardioprotective properties of omentin-1 in type2 diabetes: evidence from clinical and in vitro studies. PLoS One 2013; 8: 59697.

    Article  Google Scholar 

  17. Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 2011; 93: 21–25

    Article  CAS  Google Scholar 

  18. Yoo HJ, Hawang SY, Hong Hc, Chri Hy, Yang SJ, Seo JA, Bik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011; 10: 103.

    Article  CAS  Google Scholar 

  19. Maruyama S, Shibata R, Kikuch R, Yasuhiro I, Taku RSA, Yoshiyuki K, Hiroyuki D, et al. FAT-derived factor omentin stimulates endothelial cell function and ischemia induced revascularization via endothelial nitric oxide synthase-dependent mechanism 2011 Department of Cardiology and Molecular Cardiology, American Society of Biochemistry and Molecular Biology Osaka Japan.

  20. Shibata R, Ouchi N, Takahashiyu R, Terakura Y. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metabol Syndr 2012; 4: 37.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Hend M. Tawfeek.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tawfeek, H.M., Maghrapy, H.M., Elsaid, F.M. et al. Relationship between omentin-1 and carotid intima thickness in type 2 diabetes mellitus. Egypt J Intern Med 26, 68–74 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: